Burden of human metapneumovirus infections among children with acute respiratory tract infections attending a Tertiary Care Hospital, Kathmandu.
Bronchiolitis
Human metapneumovirus
Multiplex real-time RT-PCR
Pneumonia
Respiratory tract infections
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
07 08 2023
07 08 2023
Historique:
received:
16
02
2023
accepted:
24
07
2023
medline:
9
8
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Acute respiratory infections (ARIs) are one of the most common causes of mortality and morbidity worldwide. Every year millions of children suffer from viral respiratory tract infections (RTIs) ranging from mild to severe illnesses. Human Metapneumovirus (HMPV) is among the most frequent viruses responsible for RTIs. However, HMPV infections and their severity among children have not been explored yet in Nepal. Therefore, the study was focused on HMPV infections and other potential viral etiologies or co-infections using multiplex PCR among children attending Kanti Children's Hospital and assessed the clinical characteristics of the infections as well as found the co-infections. A hospital-based cross-sectional study was designed and a convenience sampling method was used to enroll children of less than 15 years with flu-like symptoms from both outpatients and inpatients departments over three months of the study period. HMPV infection (13.3%) was the most predominant infection among the different viral infections in children with ARIs in Kanti Children's Hospital. The HMPV was more prevalent in the age group less than three years (21.8%). Cough and fever were the most common clinical features present in all children infected with HMPV followed by rhinorrhea, sore throat, and wheezing. HMPV-positive children were diagnosed with pneumonia (42.9%), bronchiolitis (28.5%), upper respiratory tract infections (14.3%), and asthma (14.3%). The prevalence of HMPV was high in late winter (14.3%) followed by early spring (13.5%). This study provides the baseline information on HMPV and associated co-infection with other respiratory viruses for the differential diagnosis based on molecular methods and also the comparison of clinical presentations among the different respiratory syndromes.
Sections du résumé
BACKGROUND
Acute respiratory infections (ARIs) are one of the most common causes of mortality and morbidity worldwide. Every year millions of children suffer from viral respiratory tract infections (RTIs) ranging from mild to severe illnesses. Human Metapneumovirus (HMPV) is among the most frequent viruses responsible for RTIs. However, HMPV infections and their severity among children have not been explored yet in Nepal.
PURPOSE
Therefore, the study was focused on HMPV infections and other potential viral etiologies or co-infections using multiplex PCR among children attending Kanti Children's Hospital and assessed the clinical characteristics of the infections as well as found the co-infections. A hospital-based cross-sectional study was designed and a convenience sampling method was used to enroll children of less than 15 years with flu-like symptoms from both outpatients and inpatients departments over three months of the study period.
RESULTS
HMPV infection (13.3%) was the most predominant infection among the different viral infections in children with ARIs in Kanti Children's Hospital. The HMPV was more prevalent in the age group less than three years (21.8%). Cough and fever were the most common clinical features present in all children infected with HMPV followed by rhinorrhea, sore throat, and wheezing. HMPV-positive children were diagnosed with pneumonia (42.9%), bronchiolitis (28.5%), upper respiratory tract infections (14.3%), and asthma (14.3%). The prevalence of HMPV was high in late winter (14.3%) followed by early spring (13.5%).
CONCLUSIONS
This study provides the baseline information on HMPV and associated co-infection with other respiratory viruses for the differential diagnosis based on molecular methods and also the comparison of clinical presentations among the different respiratory syndromes.
Identifiants
pubmed: 37550689
doi: 10.1186/s12887-023-04208-6
pii: 10.1186/s12887-023-04208-6
pmc: PMC10405573
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
388Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Emerg Infect Dis. 2017 Aug;23(8):
pubmed: 28726613
BMC Infect Dis. 2019 Aug 30;19(1):757
pubmed: 31470805
BMJ Open. 2018 Feb 6;8(2):e019308
pubmed: 29437754
J Clin Virol. 2008 Jul;42(3):268-72
pubmed: 18455958
N Engl J Med. 2013 Feb 14;368(7):633-43
pubmed: 23406028
F1000Res. 2018 Feb 1;7:135
pubmed: 29744035
J Pediatric Infect Dis Soc. 2021 Apr 30;10(4):408-416
pubmed: 33137178
Infect Genet Evol. 2013 Apr;15:43-52
pubmed: 21292032
Pediatr Infect Dis J. 2008 Dec;27(12):1065-8
pubmed: 18978517
Virus Res. 2003 May;93(1):51-62
pubmed: 12727342
Clin Microbiol Rev. 2011 Oct;24(4):734-54
pubmed: 21976607
EClinicalMedicine. 2021 Jun 28;37:100986
pubmed: 34386754
PLoS One. 2017 Jul 13;12(7):e0180954
pubmed: 28704440
Pediatr Infect Dis J. 2010 Aug;29(8):731-5
pubmed: 20351618
Clin Infect Dis. 2017 Aug 15;65(4):604-612
pubmed: 28605562
Influenza Other Respir Viruses. 2021 Jan;15(1):72-80
pubmed: 32881286
Lancet Infect Dis. 2020 Jan;20(1):60-79
pubmed: 31678026
J Nat Sci Biol Med. 2015 Jan-Jun;6(1):3-6
pubmed: 25810626
Arch Pediatr Adolesc Med. 2010 Jan;164(1):24-30
pubmed: 20048238
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671):
pubmed: 25964453
PLoS One. 2017 Mar 16;12(3):e0173504
pubmed: 28301570
Int J Infect Dis. 2014 Aug;25:45-52
pubmed: 24841931
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
Lancet. 2010 Sep 4;376(9743):826-34
pubmed: 20816549
Vaccines (Basel). 2023 Feb 10;11(2):
pubmed: 36851289
Viruses. 2013 Jan 08;5(1):87-110
pubmed: 23299785
J Virol Methods. 2012 Nov;185(2):259-66
pubmed: 22796035
Jpn J Infect Dis. 2012 Jul;65(4):337-40
pubmed: 22814160
Int J Pediatr. 2016;2016:7235482
pubmed: 28018433
Influenza Other Respir Viruses. 2022 Jan;16(1):142-150
pubmed: 34523811
Virol J. 2011 Feb 10;8:62
pubmed: 21310026
Virol J. 2015 Oct 14;12:168
pubmed: 26467854
J Clin Microbiol. 2003 Jul;41(7):2987-91
pubmed: 12843031
Emerg Infect Dis. 2008 Jan;14(1):101-6
pubmed: 18258088
J Am Geriatr Soc. 2006 Jan;54(1):177-80
pubmed: 16420227
Braz J Microbiol. 2022 Jun;53(2):655-661
pubmed: 35118597
J Exp Stroke Transl Med. 2010 Jan 1;3(1):19-27
pubmed: 21533012
PLoS One. 2011 Apr 18;6(4):e18928
pubmed: 21533115
Nat Med. 2001 Jun;7(6):719-24
pubmed: 11385510
Cancer Control. 2016 Oct;23(4):442-445
pubmed: 27842334
Virol J. 2021 Feb 18;18(1):40
pubmed: 33602245
Int J Microbiol. 2018 Oct 28;2018:8945142
pubmed: 30510579
J Clin Virol. 2007 Jan;38(1):70-2
pubmed: 17085070
Infect Genet Evol. 2022 Dec;106:105386
pubmed: 36372116
Bull World Health Organ. 2018 Feb 1;96(2):122-128
pubmed: 29403115
J Infect Dis. 2006 Feb 1;193(3):387-95
pubmed: 16388486
J Med Virol. 2017 Apr;89(4):589-597
pubmed: 27632796
Int J Environ Res Public Health. 2020 Jan 15;17(2):
pubmed: 31952364
J Infect Dis. 2005 Feb 1;191(3):382-6
pubmed: 15633097
J Infect Dis. 2003 Nov 15;188(10):1571-7
pubmed: 14624384
Virol J. 2012 Oct 27;9:247
pubmed: 23102237